<p>Omada Health, Inc. (NASDAQ:OMDA - 获取免费报告) 在一月份经历了显著的空头头寸下降。截至 1 月 15 日，空头头寸总计为 1,498,366 股，较 12 月 31 日的 3,282,838 股下降了 54.4%。根据 903,681 股的平均交易量，当前的空头头寸比率为 1.7 天。目前，公司 2.6% 的股份被做空。</p>
<h2>Omada Health 股价上涨 1.6%</h2>
<p>NASDAQ OMDA 周四开盘价为 15.65 美元。该公司的 50 日移动平均价格为 16.19 美元，200 日移动平均价格为 19.87 美元。该公司的市值为 9.0629 亿美元，市盈率为-62.60。Omada Health 的 12 个月低点为 14.14 美元，12 个月高点为 28.40 美元。</p>
<h2>Omada Health 的内部交易</h2>
<p>在其他消息中，首席执行官 Sean P. Duffy 在 1 月 13 日（星期二）出售了 40,796 股 Omada Health 股票，交易价格为 15.95 美元，总价值为 650,696.20 美元。交易完成后，首席执行官直接持有 126,644 股公司股票，价值约为 2,019,971.80 美元。此次交易使其持股减少了 24.36%。该交易已在向证券交易委员会的备案中披露，相关信息可通过此链接访问。此外，总裁 Shao Wei-Li 在 12 月 29 日（星期一）出售了 5,618 股公司的股票，交易价格为 16.13 美元，总价值为 90,618.34 美元。交易完成后，总裁直接持有 69,079 股公司股票，价值约为 1,114,244.27 美元。此次交易使其持股减少了 7.52%。该销售的 SEC 备案提供了更多信息。在过去的 90 天内，内部人士已出售 276,893 股公司股票，价值 4,336,787 美元。</p>
<h2>对 Omada Health 的对冲基金看法</h2>
<p>机构投资者最近对该股票的持仓进行了调整。TD Waterhouse Canada Inc.在第四季度收购了 Omada Health 的新股份，价值约 32,000 美元。Raymond James Financial Inc.在第二季度收购了 Omada Health 的新股份，价值约 32,000 美元。Strs Ohio 在第三季度收购了 Omada Health 的新股份，价值约 38,000 美元。Inlight Wealth Management LLC 在第四季度收购了 Omada Health 的新股份，价值约 45,000 美元。最后，Rakuten Investment Management Inc.在第三季度收购了 Omada Health 的新股份，价值 49,000 美元。</p>
<h2>分析师的升级和降级</h2>
<p>OMDA 已经成为多份研究分析师报告的主题。Evercore ISI 在 11 月 7 日的研究报告中将 Omada Health 的目标价从 27.00 美元上调至 28.00 美元，并给予该股票 “跑赢大盘” 的评级。巴克莱在 1 月 5 日的研究报告中将 Omada Health 的目标价从 29.00 美元下调至 22.00 美元，并对该股票给予 “增持” 评级。Weiss Ratings 在 1 月 22 日的研究报告中重申了对 Omada Health 的 “卖出（d）” 评级。Needham &amp; Company LLC 在 1 月 22 日的报告中重新发布了 “买入” 评级，并设定了 28.00 美元的目标价。最后，BMO Capital Markets 在 11 月 13 日开始对 Omada Health 进行覆盖，给予 “跑赢大盘” 评级和 27.00 美元的目标价。八位分析师对该股票给予了买入评级，两位给予了持有评级，一位给予了卖出评级。根据 MarketBeat，该公司目前的共识评级为 “适度买入”，共识目标价为 25.10 美元。</p>
<p><strong>查看我们最新的 OMDA 股票报告</strong></p>
<h2>关于 Omada Health</h2>
<p>（获取免费报告）</p>
<p>Omada Health 是一家数字健康公司，专注于通过个性化、技术驱动的项目来预防和管理慢性疾病。该公司的平台结合了数据分析、行为科学和人类辅导，以支持面临风险或患有如前糖尿病、2 型糖尿病、高血压和肌肉骨骼疾病等疾病的个人。参与者通过移动应用程序或网络门户访问该项目，在那里他们可以获得量身定制的课程、健康指标反馈和持续的虚拟辅导。</p>
<p>除了核心的疾病管理服务外，Omada Health 还扩展了其服务，包括心理健康支持和数字治疗以帮助体重管理。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票，胜过 Omada Health</li>
<li>家族信托如何帮助保护您的财富</li>
<li>请勿删除，立即阅读</li>
<li>1933 年的退款：特朗普的重置可能创造即时财富</li>
<li>新法律：国会批准数字美元的设立？</li>
<li>用这四个简单步骤 “防止美联储影响” 您的银行账户</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>您现在应该投资 1,000 美元在 Omada Health 吗？</h2>
<p>在您考虑 Omada Health 之前，您需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Omada Health 并不在名单上。</p>
<p>虽然 Omada Health 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Omada Health, Inc.（纳斯达克代码：OMDA）在 1 月份经历了空头头寸的显著下降，减少了 54.4%，降至 1,498,366 股。目前的覆盖天数比率为 1.7 天，空头卖出股份占比为 2.6%。该股票开盘价为 15.65 美元，市值为 9.0629 亿美元。最近的内部交易包括首席执行官 Sean P. Duffy 出售了 40,796 股。分析师的评级意见不一，普遍评级为 “适度买入”，目标价为 25.10 美元。Omada Health 专注于慢性病的数字健康解决方案</p>

<p>Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) was the recipient of a significant decline in short interest in the month of January. As of January 15th, there was short interest totaling 1,498,366 shares, a decline of 54.4% from the December 31st total of 3,282,838 shares. Based on an average trading volume of 903,681 shares, the short-interest ratio is currently 1.7 days. Currently, 2.6% of the company's shares are sold short. Currently, 2.6% of the company's shares are sold short. Based on an average trading volume of 903,681 shares, the short-interest ratio is currently 1.7 days.</p>
<div class="lb-trans"><p>Omada Health, Inc. (NASDAQ:OMDA - 获取免费报告) 在一月份经历了显著的空头头寸下降。截至 1 月 15 日，空头头寸总计为 1,498,366 股，较 12 月 31 日的 3,282,838 股下降了 54.4%。根据 903,681 股的平均交易量，当前的空头头寸比率为 1.7 天。目前，公司 2.6% 的股份被做空。</p>
</div><h2>Omada Health Trading Up 1.6%</h2>
<div class="lb-trans"><h2>Omada Health 股价上涨 1.6%</h2>
</div><p>NASDAQ OMDA opened at $15.65 on Thursday. The business's 50-day moving average price is $16.19 and its two-hundred day moving average price is $19.87. The firm has a market capitalization of $906.29 million and a PE ratio of -62.60. Omada Health has a 12 month low of $14.14 and a 12 month high of $28.40.</p>
<div class="lb-trans"><p>NASDAQ OMDA 周四开盘价为 15.65 美元。该公司的 50 日移动平均价格为 16.19 美元，200 日移动平均价格为 19.87 美元。该公司的市值为 9.0629 亿美元，市盈率为-62.60。Omada Health 的 12 个月低点为 14.14 美元，12 个月高点为 28.40 美元。</p>
</div><h2>Insider Transactions at Omada Health</h2>
<div class="lb-trans"><h2>Omada Health 的内部交易</h2>
</div><p>In other news, CEO Sean P. Duffy sold 40,796 shares of Omada Health stock in a transaction that occurred on Tuesday, January 13th. The shares were sold at an average price of $15.95, for a total value of $650,696.20. Following the completion of the sale, the chief executive officer directly owned 126,644 shares in the company, valued at approximately $2,019,971.80. The trade was a 24.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is accessible through this link. Also, President Wei-Li Shao sold 5,618 shares of the business's stock in a transaction dated Monday, December 29th. The stock was sold at an average price of $16.13, for a total value of $90,618.34. Following the transaction, the president directly owned 69,079 shares of the company's stock, valued at approximately $1,114,244.27. The trade was a 7.52% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 276,893 shares of company stock worth $4,336,787.</p>
<div class="lb-trans"><p>在其他消息中，首席执行官 Sean P. Duffy 在 1 月 13 日（星期二）出售了 40,796 股 Omada Health 股票，交易价格为 15.95 美元，总价值为 650,696.20 美元。交易完成后，首席执行官直接持有 126,644 股公司股票，价值约为 2,019,971.80 美元。此次交易使其持股减少了 24.36%。该交易已在向证券交易委员会的备案中披露，相关信息可通过此链接访问。此外，总裁 Shao Wei-Li 在 12 月 29 日（星期一）出售了 5,618 股公司的股票，交易价格为 16.13 美元，总价值为 90,618.34 美元。交易完成后，总裁直接持有 69,079 股公司股票，价值约为 1,114,244.27 美元。此次交易使其持股减少了 7.52%。该销售的 SEC 备案提供了更多信息。在过去的 90 天内，内部人士已出售 276,893 股公司股票，价值 4,336,787 美元。</p>
</div><h2>Hedge Funds Weigh In On Omada Health</h2>
<div class="lb-trans"><h2>对 Omada Health 的对冲基金看法</h2>
</div><p>Institutional investors have recently made changes to their positions in the stock. TD Waterhouse Canada Inc. acquired a new stake in Omada Health in the fourth quarter valued at approximately $32,000. Raymond James Financial Inc. acquired a new stake in shares of Omada Health in the 2nd quarter worth about $32,000. Strs Ohio bought a new stake in Omada Health during the 3rd quarter worth approximately $38,000. Inlight Wealth Management LLC bought a new position in shares of Omada Health in the fourth quarter valued at approximately $45,000. Finally, Rakuten Investment Management Inc. purchased a new stake in Omada Health in the 3rd quarter valued at $49,000.</p>
<div class="lb-trans"><p>机构投资者最近对该股票的持仓进行了调整。TD Waterhouse Canada Inc.在第四季度收购了 Omada Health 的新股份，价值约 32,000 美元。Raymond James Financial Inc.在第二季度收购了 Omada Health 的新股份，价值约 32,000 美元。Strs Ohio 在第三季度收购了 Omada Health 的新股份，价值约 38,000 美元。Inlight Wealth Management LLC 在第四季度收购了 Omada Health 的新股份，价值约 45,000 美元。最后，Rakuten Investment Management Inc.在第三季度收购了 Omada Health 的新股份，价值 49,000 美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师的升级和降级</h2>
</div><p>OMDA has been the subject of a number of research analyst reports. Evercore ISI upped their price objective on shares of Omada Health from $27.00 to $28.00 and gave the stock an &#34;outperform&#34; rating in a research report on Friday, November 7th. Barclays decreased their target price on shares of Omada Health from $29.00 to $22.00 and set an &#34;overweight&#34; rating on the stock in a research note on Monday, January 5th. Weiss Ratings reiterated a &#34;sell (d)&#34; rating on shares of Omada Health in a research note on Thursday, January 22nd. Needham &amp; Company LLC reissued a &#34;buy&#34; rating and set a $28.00 price objective on shares of Omada Health in a report on Thursday, January 22nd. Finally, BMO Capital Markets started coverage on Omada Health in a report on Thursday, November 13th. They issued an &#34;outperform&#34; rating and a $27.00 target price for the company. Eight analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $25.10.</p>
<div class="lb-trans"><p>OMDA 已经成为多份研究分析师报告的主题。Evercore ISI 在 11 月 7 日的研究报告中将 Omada Health 的目标价从 27.00 美元上调至 28.00 美元，并给予该股票 “跑赢大盘” 的评级。巴克莱在 1 月 5 日的研究报告中将 Omada Health 的目标价从 29.00 美元下调至 22.00 美元，并对该股票给予 “增持” 评级。Weiss Ratings 在 1 月 22 日的研究报告中重申了对 Omada Health 的 “卖出（d）” 评级。Needham &amp; Company LLC 在 1 月 22 日的报告中重新发布了 “买入” 评级，并设定了 28.00 美元的目标价。最后，BMO Capital Markets 在 11 月 13 日开始对 Omada Health 进行覆盖，给予 “跑赢大盘” 评级和 27.00 美元的目标价。八位分析师对该股票给予了买入评级，两位给予了持有评级，一位给予了卖出评级。根据 MarketBeat，该公司目前的共识评级为 “适度买入”，共识目标价为 25.10 美元。</p>
</div><p><strong>View Our Latest Stock Report on OMDA</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 OMDA 股票报告</strong></p>
</div><h2>About Omada Health</h2>
<div class="lb-trans"><h2>关于 Omada Health</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.</p>
<div class="lb-trans"><p>Omada Health 是一家数字健康公司，专注于通过个性化、技术驱动的项目来预防和管理慢性疾病。该公司的平台结合了数据分析、行为科学和人类辅导，以支持面临风险或患有如前糖尿病、2 型糖尿病、高血压和肌肉骨骼疾病等疾病的个人。参与者通过移动应用程序或网络门户访问该项目，在那里他们可以获得量身定制的课程、健康指标反馈和持续的虚拟辅导。</p>
</div><p>In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.</p>
<div class="lb-trans"><p>除了核心的疾病管理服务外，Omada Health 还扩展了其服务，包括心理健康支持和数字治疗以帮助体重管理。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Omada Health</li>
<li>How a Family Trust May Be Able To Help Preserve Your Wealth</li>
<li>Do not delete, read immediately</li>
<li>Refund From 1933: Trump’s Reset May Create Instant Wealth</li>
<li>NEW LAW: Congress Approves Setup For Digital Dollar?</li>
<li>“Fed Proof” Your Bank Account with THESE 4 Simple Steps</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Omada Health</li>
<li>家族信托如何帮助保护您的财富</li>
<li>请勿删除，立即阅读</li>
<li>1933 年的退款：特朗普的重置可能创造即时财富</li>
<li>新法律：国会批准数字美元的设立？</li>
<li>用这四个简单步骤 “防止美联储影响” 您的银行账户</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Omada Health Right Now?</h2>
<div class="lb-trans"><h2>您现在应该投资 1,000 美元在 Omada Health 吗？</h2>
</div><p>Before you consider Omada Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考虑 Omada Health 之前，您需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omada Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Omada Health 并不在名单上。</p>
</div><p>While Omada Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Omada Health 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Omada Health, Inc. (NASDAQ:OMDA) 的空头头寸在一月份减少了 54.4%